The impact of first-line chemotherapy in elderly patients (pts) with advanced pancreatic cancer (APC): A mono-institutional retrospective study.

Marta Chiaravalli,Maria Grazia Maratta,Maria Bensi,Brunella Di Stefano,M. Ribelli,Diletta Barone,Enrico Gurreri,Federico Monaca,Claudia Cutigni,Cinzia Bagalà,Giampaolo Tortora,Lisa Salvatore

The impact of first-line chemotherapy in elderly patients (pts) with advanced pancreatic cancer (APC): A mono-institutional retrospective study.

2021

Marta Chiaravalli
Maria Grazia Maratta
Maria Bensi
Brunella Di Stefano
M. Ribelli
Diletta Barone
Enrico Gurreri
Federico Monaca
Claudia Cutigni
Cinzia Bagalà
Giampaolo Tortora
Lisa Salvatore

e16229Background: Pancreatic cancer median age at diagnosis is 70 years old. However, elderly pts are underrepresented in randomized clinical trials (RCTs) and chemotherapy efficacy and safety data...

Keywords:

Pancreatic cancer
Internal medicine
Medicine
age at diagnosis
first line chemotherapy
Chemotherapy
Randomized controlled trial
Oncology
Retrospective cohort study

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations